E2 ModerateModerate confidencePEM not requiredCase-ControlPeer-reviewedMachine draft
Impaired blood pressure variability in chronic fatigue syndrome--a potential biomarker.
Frith, J, Zalewski, P, Klawe, J J et al. · QJM : monthly journal of the Association of Physicians · 2012 · DOI
Quick Summary
ME/CFS is often associated with problems in the autonomic nervous system, which controls heart rate and blood pressure. This study measured how heart rate and blood pressure respond to position changes in 68 ME/CFS patients and 68 healthy controls. The researchers found that ME/CFS patients showed abnormal patterns in blood pressure variability that could potentially be used as a diagnostic test.
Why It Matters
Autonomic dysfunction is a recognized but poorly understood feature of ME/CFS. This study provides objective, measurable physiological markers that could potentially improve diagnosis and validate the biological basis of the condition for both patients seeking recognition and clinicians developing treatments.
Observed Findings
- At rest, ME/CFS patients showed significantly increased low-frequency (sympathetic) heart rate variability and decreased high-frequency (parasympathetic) heart rate variability compared to controls
- Total diastolic blood pressure spectral power was significantly increased in ME/CFS with a shift toward sympathetic and away from parasympathetic components
- On standing, ME/CFS patients demonstrated blunted systolic blood pressure variability response compared to controls, with reduced both sympathetic and parasympathetic components
- A three-parameter composite of resting blood pressure variability measures achieved 77% sensitivity and 53% specificity for distinguishing ME/CFS from controls
Inferred Conclusions
- ME/CFS is characterized by objective, measurable abnormalities in blood pressure and heart rate variability suggesting sympathetic overdrive and parasympathetic insufficiency
- Blood pressure variability parameters, particularly at rest, have potential as a bedside diagnostic biomarker for ME/CFS
- Abnormal cardiovascular responses to postural change in ME/CFS may reflect underlying autonomic nervous system dysfunction
Remaining Questions
- Do these blood pressure variability abnormalities improve or worsen with ME/CFS treatment or disease progression?
- How do these autonomic markers correlate with symptom severity, post-exertional malaise, or functional capacity?
What This Study Does Not Prove
This study does not prove that blood pressure variability abnormalities cause ME/CFS symptoms, nor does it establish whether these changes are specific to ME/CFS or present in other conditions with autonomic dysfunction. The moderate specificity (53%) means the test cannot reliably confirm diagnosis on its own without additional clinical assessment.
Tags
Symptom:Orthostatic IntoleranceFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1093/qjmed/hcs085
- PMID
- 22670061
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →